Research Article
The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma
Table 1
Clinicopathological and demographic characteristics of patients with cutaneous melanoma (TCGA, Provisional).
| Characteristics | Cases number | Percentage (%) |
| Age | | | ≤58 | 227 | 50.2 | >58 | 225 | 49.8 | Gender | | | Male | 280 | 61.9 | Female | 172 | 38.1 | AJCC stage | | | Stage I | 75 | 16.6 | Stage II | 139 | 30.8 | Stage III | 167 | 36.9 | Stage IV | 21 | 4.6 | Unknown | 50 | 11.1 | Tumor thickness (mm) | | | ≤1.00 | 57 | 12.6 | 1.01~2.00 | 77 | 17.0 | 2.01~4.00 | 68 | 15.0 | >4.00 | 146 | 32.3 | Unknown | 104 | 23.0 | Ulceration | | | Absent | 142 | 31.4 | Present | 163 | 36.1 | Unknown | 147 | 32.5 | Overall survival | | | Living | 236 | 52.2 | Deceased | 216 | 47.8 |
|
|